pipette
ESEspañol

Human genetics implicates a BACH2–NRF2 axis in fetal haemoglobin activation

Chun-Jie Guo, Uma P. Arora, Xiaoheng Cheng, Wanying Xu, Liam D. Cato, Rick Li, Henry Y. Lu, Andrew Lee, Fulong Yu, Gaurav Agarwal, Peng Lyu, Tianyi Ye, Mateusz Antoszewski, Mariel Wissmann, Baraka Stewart Mkumbe, Supachai Ekwattanakit, Patrick Deelen, Liberata Mwita, Raphael Zozimus Sangeda, Thidarat Suksangpleng, Suchada Riolueang, Paola G. Bronson, Dirk S. Paul, Emily Kawabata, William John Astle, Francois Aguet, Kristin Ardlie, Aitzkoa Lopez de Lapuente Portilla, Guolian Kang, Yingze Zhang, Mehdi syed Nouraie, Victor R. Gordeuk, Mark T. Gladwin, Melanie E. Garrett, Allison E. Ashley‐Koch, Marilyn J. Telen, Brian Custer, Shannon Kelly, Carla Luana Dinardo, Éster Cerdeira Sabino, Paula Loureiro, Anna Bárbara Carneiro-Proietti, Cláudia Maximo, Adriana Mendez, Angelika Hammerer‐Lercher, Julie Makani, Vivien Sheehan, Mitchell J. Weiss, Lude Franke, Björn Nilsson and 4 more

Peer-reviewed journal

In the authors' words

Abstract Human genetic studies have identified key regulators of fetal haemoglobin (HbF) expression, including BCL11A, resulting in therapeutic advances 1–8 . Yet the mechanisms by which HbF expression is activated remain incompletely understood 9 . Here we conduct a large multi-ancestry genome-wide association study of HbF levels in 28,279 individuals that identifies 91 conditionally independent associations across 12 genomic regions. In one previously uncharacterized associated region, the high-HbF-linked causal variant rs1010474-C reduces BACH2 expression and elevates HbF levels. Direct perturbation or inhibition of BACH2 likewise increases HbF expression. Mechanistically, BACH2 restrains activation of the HbF-encoding γ-globin genes, while loss of BACH2 enhances NRF2 chromatin occupancy and promotes the formation of activation foci at the γ-globin genes. Although BACH2 and NRF2 binding motifs in the γ-globin promoters overlap, they can be selectively edited to activate or repress γ-globin, respectively, and do so independently of BCL11A. These findings illustrate how human genetic variation continues to advance our understanding of therapeutically relevant regulatory mechanisms underlying HbF expression.

Main resultThe abstract does not state a limitation.

Appeared: Friday, October 2. Nature. Peer-reviewed journal.

DOI: 10.1038/s41586-026-11113-2